IL6 rs2069837: Understanding the Promoter Variant
The rs2069837 variant is a single nucleotide polymorphism located in the promoter region of the IL6 gene. It is studied for its potential influence on baseline systemic inflammation levels and various cardiovascular risk biomarkers.
What each genotype means
Baseline inflammatory profile
This genotype represents the common baseline state for the IL6 promoter region. Research into this variant often uses this genotype as a reference point when comparing associations with inflammatory conditions or autoimmune susceptibility. It is not a diagnostic indicator, and any concerns regarding systemic inflammation should be discussed with a healthcare provider.
This is the most common genotype in European populations, where the minor allele frequency is approximately 0.06.
Increased susceptibility association
Individuals with this genotype carry one copy of the G allele, which has been investigated for associations with increased susceptibility to certain inflammatory conditions, such as Takayasu arteritis and atopic dermatitis. Because these associations are based on statistical population studies, they do not predict individual health outcomes. Please consult with a clinician if you have concerns about inflammatory symptoms.
This genotype is observed in a significant portion of the population, though it is less common than the homozygous CC state in European cohorts.
Elevated inflammatory risk marker
Carrying two copies of the G allele has been linked in some studies to a higher statistical risk for specific immune-mediated conditions compared to those without the variant. These findings are based on complex genetic associations and do not guarantee the development of any disease. You should discuss your overall health and any relevant family history with your doctor rather than focusing on this single genetic marker.
This genotype is relatively rare in European populations but occurs at higher frequencies in some East Asian populations where the G allele is more prevalent.
What is rs2069837?
The variant rs2069837 is a specific genetic change, often referred to as a -572 C/G polymorphism, situated within the promoter region of the interleukin-6 (IL6) gene. A promoter is a regulatory segment of DNA that acts like a switch, determining when and how much of a gene's protein product is produced. By residing in this critical area, rs2069837 may influence the transcriptional activity of the IL6 gene. In genetic databases, this variant is tracked to understand how subtle differences in our DNA sequence can lead to variations in biological processes. Because it is located in a regulatory region rather than a coding region, it does not change the structure of the IL6 protein itself, but rather the efficiency or frequency with which the body manufactures it.
The Role of the IL6 Gene
The IL6 gene provides instructions for making interleukin-6, a multifunctional cytokine that plays a central role in the body's immune response. Interleukin-6 acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine, helping the body respond to infections, tissue damage, and stress. It is a key player in the acute-phase response, signaling the liver to produce proteins that manage inflammation. Because of its broad influence on the immune system, IL6 is frequently studied in the context of chronic inflammatory conditions and cardiovascular health. Maintaining a balanced level of IL6 is essential for homeostasis, as both chronically low and chronically high levels can be associated with different physiological states and health outcomes.
Research and Evidence Strength
Research into rs2069837 has primarily focused on its association with systemic inflammation and cardiovascular risk markers. While some studies have explored its potential impact on baseline IL-6 levels, the evidence remains limited and sometimes inconsistent across different cohorts. It is important to note that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for any individual. Many factors, including environment, lifestyle, and other genetic variants, contribute to cardiovascular health. Current scientific literature often highlights the complexity of IL6 signaling, noting that findings can vary significantly based on the ancestry of the study population. Consequently, the clinical significance of this specific variant is still being evaluated by the scientific community, and it is not currently used as a standard diagnostic tool.
Population Frequency
The frequency of the rs2069837 variant varies notably across different global populations. Data indicates a minor allele frequency (MAF) of approximately 0.06 in European populations, while it is significantly more common in East Asian populations, where the frequency can reach up to 0.45. This wide disparity underscores the importance of considering ancestry when interpreting genetic data. Because the variant is common in some groups and rare in others, researchers must be cautious when generalizing findings from one population to another. These frequency differences are a standard feature of human genetic diversity and are tracked by large-scale genomic projects to ensure that scientific research remains representative of global human variation.
Interpreting Your Genetic Information
If you have received information about your rs2069837 genotype, it is helpful to view it as one small piece of a much larger biological puzzle. Genetic variants like this are not diagnostic; they do not predict the development of disease with certainty. Instead, they represent statistical trends observed in large groups of people. You cannot change your genotype, but you can focus on modifiable lifestyle factors—such as diet, exercise, and stress management—that are known to influence systemic inflammation and cardiovascular health. If you are concerned about your cardiovascular risk or inflammatory markers, the most effective step is to consult with a healthcare professional. They can interpret your overall health profile, including clinical blood tests, to provide personalized guidance that is far more accurate than any single genetic variant.
How common is this variant?
The minor allele frequency is approximately 0.06 in Europeans and reaches up to 0.45 in East Asian populations.
Frequently asked questions
Does rs2069837 mean I have high inflammation?
No, having a specific genotype for rs2069837 does not mean you have high inflammation. Inflammation is a complex process influenced by many factors, and this variant is only one of many potential contributors.
Can I change my IL6 levels through diet?
Lifestyle factors such as a balanced diet, regular physical activity, and stress reduction are known to support healthy inflammatory responses. You should discuss any specific health concerns or lifestyle changes with your doctor.
Is this variant a risk factor for heart disease?
While some studies investigate the link between IL6 variants and cardiovascular markers, the evidence is limited and mixed. Genetic variants are not diagnostic and should not be used to predict individual disease risk.
Should I get tested for this variant?
There is no clinical recommendation to test for this variant for diagnostic purposes. If you have concerns about your cardiovascular health, standard clinical blood tests are more informative than genetic testing for this specific SNP.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2069837?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL6
Promoter region polymorphism (-572G>C) in interleukin-6 affecting baseline systemic inflammatory tone and cardiovascular disease risk.
This variant is associated with variations in C-reactive protein levels, a key marker of systemic inflammation.
This variant shows a borderline association with late-life survival in European cohorts.
A promoter variant in the Interleukin-6 gene that influences systemic inflammation levels (C-Reactive Protein).